Emicizumab and Filgrastim-aafi Intravenous, Subcutaneous
Determining the interaction of Emicizumab and Filgrastim-aafi Intravenous, Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: n.a.
Generic Name: filgrastim
Brand name: Neupogen, Neupogen SingleJect, Nivestym, Zarxio
Synonyms: Filgrastim-aafi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-Filgrastim-sndz
- Emicizumab-Finacea
- Emicizumab-Finacea (Azelaic Acid Foam)
- Emicizumab-Finacea (Azelaic Acid Gel)
- Emicizumab-Finacea Foam
- Emicizumab-Finacea Plus
- Filgrastim-aafi Intravenous, Subcutaneous-Emicizumab-kxwh
- Filgrastim-aafi Intravenous, Subcutaneous-Emicizumab-kxwh Subcutaneous
- Filgrastim-aafi Intravenous, Subcutaneous-Emla
- Filgrastim-aafi Intravenous, Subcutaneous-Emla Topical
- Filgrastim-aafi Intravenous, Subcutaneous-Emo-Cort Scalp Solution Topical application
- Filgrastim-aafi Intravenous, Subcutaneous-Emo-Cort Topical application